Cargando…
Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608437/ https://www.ncbi.nlm.nih.gov/pubmed/31511646 http://dx.doi.org/10.1038/s41388-019-0982-4 |
| _version_ | 1783604839351058432 |
|---|---|
| author | Yang, Tingting Ren, Chune Qiao, Pengyun Han, Xue Wang, Li Lv, Shijun Sun, Yonghong Liu, Zhijun Du, Yu Yu, Zhenhai |
| author_facet | Yang, Tingting Ren, Chune Qiao, Pengyun Han, Xue Wang, Li Lv, Shijun Sun, Yonghong Liu, Zhijun Du, Yu Yu, Zhenhai |
| author_sort | Yang, Tingting |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7608437 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76084372020-11-05 Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer Yang, Tingting Ren, Chune Qiao, Pengyun Han, Xue Wang, Li Lv, Shijun Sun, Yonghong Liu, Zhijun Du, Yu Yu, Zhenhai Oncogene Correction Nature Publishing Group UK 2019-09-11 2020 /pmc/articles/PMC7608437/ /pubmed/31511646 http://dx.doi.org/10.1038/s41388-019-0982-4 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Yang, Tingting Ren, Chune Qiao, Pengyun Han, Xue Wang, Li Lv, Shijun Sun, Yonghong Liu, Zhijun Du, Yu Yu, Zhenhai Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| title | Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| title_full | Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| title_fullStr | Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| title_full_unstemmed | Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| title_short | Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| title_sort | correction: pim2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608437/ https://www.ncbi.nlm.nih.gov/pubmed/31511646 http://dx.doi.org/10.1038/s41388-019-0982-4 |
| work_keys_str_mv | AT yangtingting correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT renchune correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT qiaopengyun correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT hanxue correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT wangli correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT lvshijun correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT sunyonghong correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT liuzhijun correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT duyu correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer AT yuzhenhai correctionpim2mediatedphosphorylationofhexokinase2iscriticalfortumorgrowthandpaclitaxelresistanceinbreastcancer |